New Biomarkers of Inflammation Identified as Risk Factors for Neuropathy
24.08.2018 · DDZ Deutsches Diabetes-Zentrum
Although many patients suffer from polyneuropathy, relatively little is currently known about its development, which also limits the therapeutic options. It is known that inflammatory processes contribute to other diabetic...
A molecular switch may serve as new target point for cancer and diabetes therapies
13.08.2018 · FMP Leibniz-Forschungsinstitut für Molekulare Pharmakologie
If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin...
Alexander von Humboldt Research Fellow at FLI
13.08.2018 · FLI Leibniz Institute on Aging - Fritz Lipmann Institute
Ukrainian cell biologist Dr. Yuliya Kurlishchuk has received a research fellowship for postdocs from the Alexander von Humboldt Foundation. With this funding, she is now a guest at the Leibniz Institute on Aging – Fritz Lipmann...
Healthy Ageing - Forschung aus erster Hand
Bioactive compound improves memory
Better understanding cardiovascular diseases